Sreenija Yarlagadda, MD
Instructor
Department:
SOM-Radiation/Oncology
Email:
syarlagadda4@umc.edu
Work Phone:
(601) 984-2550
Publications
Case Reports | |
| Madsen J, Fraga-Braghiroli N, Rubens M, Yarlagadda S, Kalman NS, Reflectance confocal microscopy mapping of nonmelanoma skin cancers to guide definitive radiation therapy: Case series. JAAD case reports, 2025 Dec;66:50-51 | 2025 |
| Yarlagadda S, Weiss Y, Chuong MD, Bassiri N, Gutierrez AN, Kotecha R, Mehta MP, Mittauer KE, Case report: Intrafraction dose-guided tracking for gastrointestinal organ-at-risk isotoxicity delivery on an MR-guided radiotherapy system. Frontiers in oncology, 2024;14:1357916 | 2024 |
| Damle A, Sreenija Y, Mathews NR, Nair K, Philp A, Pavithran K, Paulose RR, Malignant Gastrointestinal Neuroectodermal Tumour-Case Report with Review of Literature. Journal of gastrointestinal cancer, 2021 Sep;52(3):1125-1130 | 2021 |
Observational Study | |
| Dutta D, Reddy SK, Kamath RK, Sreenija Y, Nair H, Sashidharan A, Remesan Nair RA, Pushpuja KU, Kannan R, Edappattu A, Haridas NK, Jose WM, Keechilat P, Prospective Evaluation of Response to Treatment, Survival Functions, Recurrence Pattern and Toxicity Profile in Indian Patients with Oligo-Brain Metastasis Treated with Only SRS. Neurology India, 2023 Jan-Feb;71(1):62-71 | |
Journal Article | |
| Yarlagadda S, Tolakanahalli R, Zhang Y, Wieczorek DJ, Bejarano T, Lee YC, Akdemir E, Hall MD, Press RH, Bander ED, McDermott MW, Gutierrez AN, Mehta MP, Kotecha R, Quantifying risk of radiation necrosis: Normal tissue complication probability modeling following stereotactic radiosurgery for small brain metastases in the modern era. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2026 Jan;214:111266 | 2026 |
| Yarlagadda S, Maharaj A, Nong T, Gonzalez AV, Guerra NC, Paterniti-Ruscin DM, Castro-Hall E, Carvallo N, Gonzalez L, Rubens M, Kaiser A, Kalman NS, Time Course and Determinants of Acute Dysgeusia in Patients Receiving Head and Neck Radiation Therapy. Advances in radiation oncology, 2026 Aug;11(8):102054 | 2026 |
| Kotecha R, Akdemir EY, Din NU, Yarlagadda S, Reyes M, Nitti F, Gutierrez AN, Wieczorek DJM, Lee YC, Tolakanahalli R, Bander ED, Mcdermott MW, Ahluwalia MS, Mehta MP, Comprehensive Performance Testing and External Validation of an AI Algorithm to Detect and Segment Brain Metastases. Neuro-oncology, 2026 Jul 8; | 2026 |
| Herrera RA, Akdemir EY, Kotecha R, Mittauer KE, Hall MD, Kaiser A, Bassiri-Gharb N, Kalman NS, Weiss Y, Romaguera T, Alvarez D, Yarlagadda S, Tolakanahalli R, Gutierrez AN, Mehta MP, Chuong MD, Evolving Trends and Patterns of Utilization of Magnetic Resonance-Guided Radiotherapy at a Single Institution, 2018-2024. Cancers, 2025 Jan 10;17(2) | 2025 |
| Akdemir EY, Herrera R, Gurdikyan S, Hodgson LC, Yarlagadda S, Kaiser A, Press RH, Mittauer KE, Bassiri-Gharb N, Tolakanahalli R, Gutierrez AN, Mehta MP, Chuong MD, Kotecha R, Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Infradiaphragmatic Oligometastatic Disease: Disrupting the One-Size-Fits-All Paradigm. International journal of radiation oncology, biology, physics, 2025 Jul 1;122(3):739-751 | 2025 |
| Akdemir EY, Gurdikyan S, Reyes TC, Odia Y, Menendez MAR, Yarlagadda S, Gal O, Hall MD, Press RH, Wieczorek DJ, Lee YC, Tolakanahalli R, Gutierrez AN, McDermott MW, Ahluwalia MS, Mehta MP, Kotecha R, Integrating a novel tablet-based digital neurocognitive assessment tool in brain metastases patients. Journal of neuro-oncology, 2025 Aug;174(1):121-129 | 2025 |
| Yarlagadda S, Belnap S, Candela J, Kutuk T, Reyes TC, Ramirez Menendez M, Hall M, Press R, Odia Y, Mehta M, McDermott M, Kotecha R, Correlation Between Neurocognitive Outcomes and Neuroaxonal Connectome Alterations After Whole Brain Radiotherapy: A Proof-of-Concept Study. Cancers, 2025 May 23;17(11) | 2025 |
| Yarlagadda S, Rohe RM, McNeill V, Nemec JR, Tohtz CP, Fellows ZW, McAllister N, Rzepczynski AE, McConnell KA, Kalman NS, Tubarial gland sparing for oropharyngeal cancer: Feasibility with intensity modulated proton therapy & intensity modulated radiation therapy. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2025 Jun;207:110882 | 2025 |
| Yarlagadda S, Zhang Y, Saxena A, Kutuk T, Tolakanahalli R, Appel H, Herrera R, Hall MD, Press RH, Wieczorek DJJ, Lee YC, Bejarano T, McDermott MW, Gutierrez AN, Mehta MP, Kotecha R, Assessment of outcomes and machine Learning-based models to predict local failure risk following stereotactic radiosurgery for small brain metastases. Journal of neuro-oncology, 2025 Sep;174(3):635-643 | 2025 |
| Khatri VM, Mestres-Villanueva MA, Daniel S, Yarlagadda S, Doniparthi A, Upadhyay R, Mills MN, Oliver DE, Yu HM, Palmer JD, Stover DG, Williams NO, Mahtani RL, Ahluwalia MS, Soyano AE, Soliman HH, Han HS, Kotecha R, Beyer SJ, Ahmed KA, Sacituzumab govitecan and stereotactic radiosurgery in the management of HER2 negative breast cancer brain metastases: a multi-institutional report. Journal of neuro-oncology, 2025 Dec;175(3):1435-1441 | 2025 |
| Akdemir EY, Gutierrez AN, Zhang Y, Yarlagadda S, Gurdikyan S, DiStefano J, Wieczorek DJ, Lee YC, Tolakanahalli R, Hall MD, Press RH, McDermott MW, Bander ED, Guo WY, Tu E, Mehta MP, Kotecha R, Evaluating the efficacy of a federated AI algorithm in assisting in the detection and segmentation of brain metastases: limitations and opportunities. Journal of neuro-oncology, 2025 Nov 5;176(1):70 | 2025 |
| Yarlagadda S, Kutuk T, Jimenez RE, Rubens MB, Hall M, Eiseler NT, Kalman NS, Dose-Escalated Preoperative Proton Therapy for Retroperitoneal Sarcomas: Initial Outcomes of a New Treatment Paradigm. Advances in radiation oncology, 2024 Apr;9(4):101431 | 2024 |
| La Rosa A, Mittauer KE, Bassiri N, Rzepczynski AE, Chuong MD, Yarlagadda S, Kutuk T, McAllister NC, Hall MD, Gutierrez AN, Tolakanahalli R, Mehta MP, Kotecha R, Accelerated Hypofractionated Magnetic Resonance Guided Adaptive Radiation Therapy for Ultracentral Lung Tumors. Tomography (Ann Arbor, Mich.), 2024 Jan 17;10(1):169-180 | 2024 |
| Yarlagadda S, McAllister N, Rzepczynski AE, Kutuk T, Kalman NS, Tubarial gland sparing with intensity modulated radiation therapy for oropharyngeal cancers: A pilot study of dosimetric feasibility. Head & neck, 2024 Jul;46(7):1582-1588 | 2024 |
| Kutuk T, Zhang Y, Akdemir EY, Yarlagadda S, Tolakanahalli R, Hall MD, La Rosa A, Wieczorek DJ, Lee YC, Press RH, Appel H, McDermott MW, Odia Y, Ahluwalia MS, Gutierrez AN, Mehta MP, Kotecha R, Comparative evaluation of outcomes amongst different radiosurgery management paradigms for patients with large brain metastasis. Journal of neuro-oncology, 2024 Aug;169(1):105-117 | 2024 |
| Roof SA, Jabalee J, Rettig EM, Chennareddy S, Ferrandino RM 2nd, Chen S, Posner MR, Genden EM, Chai RL, Sims J, Thrash E, Stern SJ, Kalman NS, Yarlagadda S, Raben A, Clements L, Mendelsohn A, Kaczmar JM, Pandey Y, Bhayani M, Del Vecchio Fitz C, Hanna GJ, Utility of TTMV-HPV DNA in resolving indeterminate findings during oropharyngeal cancer surveillance. Oral oncology, 2024 Aug;155:106874 | 2024 |
| Gonzalez L, Rubens M, Yarlagadda S, Rabinowits G, Kalman NS, Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma. Radiation oncology (London, England), 2024 Oct 11;19(1):142 | 2024 |
| Khatri VM, Mestres-Villanueva MA, Yarlagadda S, Doniparthi A, Smith DB, Nakashima JY, Bryant JM, Zhao D, Upadhyay R, Mills MN, Oliver DE, Yu HM, Palmer JD, Williams NO, Mahtani RL, Ahluwalia MS, Soliman HH, Han HS, Soyano AE, Kim Y, Kotecha R, Beyer SJ, Ahmed KA, Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastases. NPJ breast cancer, 2024 Nov 21;10(1):100 | 2024 |
| Hanna GJ, Roof SA, Jabalee J, Rettig EM, Ferrandino R, Chen S, Posner MR, Misiukiewicz KJ, Genden EM, Chai RL, Sims J, Thrash E, Stern SJ, Kalman NS, Yarlagadda S, Raben A, Clements L, Mendelsohn A, Kaczmar JM, Pandey Y, Bhayani M, Gupta P, Kuperwasser C, Del Vecchio Fitz C, Berger BM, Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance. Clinical cancer research : an official journal of the American Association for Cancer Research, 2023 Oct 13;29(20):4306-4313 | 2023 |
| Mittauer KE, Yarlagadda S, Bryant JM, Bassiri N, Romaguera T, Gomez AG, Herrera R, Kotecha R, Mehta MP, Gutierrez AN, Chuong MD, Online adaptive radiotherapy: Assessment of planning technique and its impact on longitudinal plan quality robustness in pancreatic cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2023 Nov;188:109869 | 2023 |
| Dutta D, Tatineni T, Yarlagadda S, Gupte A, Reddy SK, Madhavan R, Nair H, Sasidharan A, Kannan R, Pottayil SG, Holla R, Sudhindran S, Hepatocellular carcinoma patients with portal vein thrombosis treated with robotic radiosurgery: Interim results of a prospective study. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2021 Aug;40(4):389-401 | 2021 |
| Yarlagadda Sreenija, Ajay Sasidharan, P Shanmuga Sundaram, Debnarayan Dutta Role of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Detection of Portal Vein Tumor Thrombosis in Hepatocellular Carcinoma Journal of Gastroenterology & Hepatology Reports. SRC/JGHR-135 | |
| Sreenija Y, Reddy SK, Dutta D. Relevance of Child Pugh Scoring System as Inclusion Criteria in Hepatocellular Carcinoma Management Japanese Journal of Gastroenterology, Hepatology | |
| Kutuk T, Tolakanahalli R, Chaswal V, Yarlagadda S, Herrera R, Appel H, La Rosa A, Mishra V, Wieczorek DJJ, McDermott MW, Siomin V, Mehta MP, Odia Y, Gutierrez AN, Kotecha R, Surgically targeted radiation therapy (STaRT) for recurrent brain metastases: Initial clinical experience. Brachytherapy, 2023 Nov-Dec;22(6):872-881 | |
| Dutta D, Yarlagadda S, Kalavagunta S, Nair H, Sasidharan A, Nimmya SK, Kannan R, George S, Edappattu A, Haridas NK, Jose WM, Keechilat P, Valsan A, Koshy A, Gopalakrishna R, Sadasivan S, Gopalakrishnan U, Balakrishnan D, Sudheer OV, Surendran S, Co-relation of Portal Vein Tumour Thrombus Response With Survival Function Following Robotic Radiosurgery in Vascular Invasive Hepatocellular Carcinoma. Journal of clinical and experimental hepatology, 2024 Sep-Oct;14(5):101404 | |
Abstracts | |
| McConnell K, Rohe R, Yarlagadda S, Gutierrez A, Kalman N, Wroe A. Comprehensive Dosimetric and Delivery Tradeoffs for Proton Dynamic Arc Therapy Vs. IMPT for Nasopharyngeal Irradiation 2026 Joint AAPM | 2026 |
| Yarlagadda S, Young G, Rohe RM, McNeill V, Nemec J, Tohtz C, et al. Significance of Submandibular Gland Transfer on Salivary Dose Sparing in Intensity Modulated Proton Therapy International Journal of Radiation Oncology*Biology*Physics. 2026 May 1;SBRT Trials: From Clinical Trials to Your Clinic, Vol. 2125(1):e33 | 2026 |
| Yarlagadda S, Acosta M, Carvallo N, McConnell KA, Kalman NS. A Deep Quantitative Assessment of Metabolic Mucosal Changes with Variable Relative Biological Effectiveness of Head and Neck Proton Therapy. International Journal of Radiation Oncology, Biology, Physics 2025;123:S100 | 2025 |
| Akdemir EYY, Tolakanahalli RP, Rivera CM, Wang D, Yarlagadda S, Gutierrez A, et al. Decoding Auto-Segmentation: A Deep Qualitative Analysis of Commercial Tools for Organs-at-Risk Delineation. International Journal of Radiation Oncology, Biology, Physics 2025;123:e2–3. | 2025 |
| Akdemir EYY, Kotecha R, Gurdikyan S, Herrera R, Fellows Z, Yarlagadda S, et al Timing and Predictors of Grade 3 Lymphopenia in Lung Cancer Patients Undergoing Proton Chemoradiotherapy International Journal of Radiation Oncology, Biology, Physics 2025;123:e460–1. | 2025 |
| Yarlagadda S, Tolakanahalli RP, Zhang Y, Wieczorek DJ, Bejarano T, Lee YC, et al. Normal Tissue Complication Probability Model Predicting the Risk of Radiation Necrosis after Stereotactic Radiosurgery for Small Brain Metastases International Journal of Radiation Oncology, Biology, Physics 2025;123:e311. | 2025 |
| Yarlagadda S, Rohe RM, McNeill V, Nemec JR, Tohtz CP, Fellows ZW, et al. Tubarial gland sparing for oropharyngeal cancer: Feasibility with Intensity Modulated Proton Therapy & Intensity Modulated Radiation Therapy Radiotherapy and Oncology. 2025 May 1;206:S930–1 | 2025 |
| Akdemir EY, Gurdikyan S, Reyes TC, Odia Y, Press RH, Yarlagadda S, et al. The Neurocognitive Effects of Intracranial Progression & Subsequent Courses of Stereotactic Radiosurgery: Lessons Learned from a Prospective Registry Radiotherapy and Oncology. 2025 May 1;206:S650–1 | 2025 |
| Yarlagadda S, Zhang Y, Wieczorek DJJ, Tolakanahalli R, Saxena A, Bejarano T, et al. Estimating Radiation Necrosis Risk following Single-fraction Stereotactic Radiosurgery in the Modern Era: An In-Depth Dose-Volume Analysis Radiotherapy and Oncology. 2025 May 1;206:S707–8. | 2025 |
| Yarlagadda S, Kalman N, Jimenez R, Eiseler N, Roy M, Simone C, et al. Multi-institutional experience of pre-operative proton therapy for retroperitoneal sarcoma in the prospective Proton Collaborative Group (PCG) Registry Int J Part Ther 2024;11:100071 | 2024 |
| Scott A Roof, James Jabalee, Eleni M Rettig, Rocco Ferrandino, Sida Chen, Marshall R Posner, Krzysztof J Misiukiewicz, Eric M Gender, Raymond L Chai, John Sims, Elaine Thrash, Scott J Stern, Noah S Kalman, Sreenija Yarlagadda, Adam Raben, Lydia Clements, Abie Mendelsohn, John M Kaczmar, Yadav Pandey, Mihir Bhayani, Catherine DV Fitz, Glenn J Hanna Immediate post-treatment detection of minimal residual disease in HPV-Driven oropharyngeal cancer is associated with high risk of recurrence. Clin Cancer Res 1 November 2024; 30 (21_Supplement): B022 | 2024 |
| La Rosa A, Yarlagadda S, Kutuk T, Akdemir EY, Gal O, Press RH, Hall MD, Lee Y, Wieczorek DJ, Tolakanahalli RP, Gutierrez A. Impact of Systemic Therapy Selection on Brain Metastasis Outcomes in Lung Cancer Patients Treated with Stereotactic Radiosurgery International Journal of Radiation Oncology, Biology, Physics. 2024 Oct 1;120(2):e248. | 2024 |
| Yarlagadda S, Zhang Y, Saxena A, Kutuk T, Tolakanahalli RP, Appel H, La Rosa A, Hall MD, Press RH, Wieczorek DJ, Lee YC. Development of a Machine Learning-Based Tool to Predict Local Failure after Stereotactic Radiosurgery for Small Brain Metastases International Journal of Radiation Oncology, Biology, Physics. 2024 Oct 1;120(2):e292. | 2024 |
| Yarlagadda S, Almanzar AP, Rubens M, Kalman NS. Taste Changes in Patients Receiving Head and Neck Radiation–Initial Analysis from a Prospective Study. International Journal of Radiation Oncology, Biology, Physics. 2024 Oct 1;120(2):e804. | 2024 |
| Rosa AL, Kotecha R, Wieczorek DJD, Lee YC, Mittauer KE, Key S, Nema BG, Yarlagadda S et al. Comparison of fractionated SRS treatment quality amongst multiple stereotactic delivery platforms. Radiother Oncol 2024;194:S891–4. | 2024 |
| Rosa AL, Chundru SN, Tom MC, Vuong HV, Kutuk T, Yarlagadda S, et al. 18F-Fluciclovine PET/CT characterization of large BM treated with SSRS: phase 1 interim analysis Radiother Oncol 2024;194:S759–62 | 2024 |
| Rosa AL, Mittauer KE, Rzepczynski AE, Chuong MD, Yarlagadda S, Kutuk T, et al. Inter-fractional glioblastoma dynamic changes observed during chemoradiotherapy with MR Linac Radiother Oncol 2024;194:S756–9. | 2024 |
| Yarlagadda S, Rios AFLR de los, Wieczorek DJJ, Odia Y, Kutuk T, Reyes TC, et al. Evaluating dose parameters for cognitive decline post-radiosurgery measured by App-based assessment Radiother Oncol 2024;194:S841–2 | 2024 |
| Yarlagadda S, Belnap SC, Kutuk T, Candela J, Reyes TC, Menendez MAR, et al. Connectome analysis & cognitive outcomes post Whole-brain RT: Prospective registry’s first analysis. Radiother Oncol 2024;194:S769–71 | 2024 |
| Yarlagadda S, Zhang Y, Saxena A, Kutuk T, Tolakanahalli R, Appel H, et al. Machine Learning to predict time to local failure & radionecrosis post-brain metastasis radiosurgery. Radiother Oncol 2024;194:S794–6. | 2024 |
| Gal O, Yarlagadda S, Hall MD, Press RH, Wieczorek DJ, Lee YC, et al. Brain metastases distribution width (BMDW): a novel metric to predict distant brain failure following stereotactic radiosurgery in patients with multiple brain metastases. Neuro-Oncol Adv. 2024 Aug 1; 6(Supplement_1):i20–1. | 2024 |
| La Rosa A, Kutuk T, Yarlagadda S, Fellows ZW, Press R, Hall M, Wroe A, Gutierrez A, Mehta M, Kotecha R. Temporally modulated pulsed proton re-irradiation (tmppr) for patients with recurrent high-grade intracranial malignancies. International Journal of Particle Therapy. 2024 Jun 1;12:100192. | 2024 |
| La Rosa A, Kutuk T, Yarlagadda S, Fellows ZW, Press R, Hall M, Wroe A, Gutierrez A, Mehta M, Kotecha R Proton craniospinal irradiation (pcsi) for leptomeningeal disease from solid tumors: initial institutional experience. International Journal of Particle Therapy. 2024 Jun 1;12:100272. | 2024 |
| La Rosa, A., Yarlagadda, S., Kutuk, T., Akdemir, E. Y., Gal, O., Albretch, F., Kaywin, P., Press, R. H., Hall, M. D., Mehta, M. P., & Kotecha, R Impact of systemic therapy activity on brain metastasis outcomes in a female and hispanic-dominant lung cancer cohort treated with stereotactic radiosurgery Neuro-Oncology Advances, 6(Suppl 1), i18–i19. | 2024 |
| Yarlagadda S, La Rosa A, Odia Y, Kutuk T, Reyes TC, Menendez M, Press R, Hall M, Mehta M, Kotecha R. Post-radiotherapy neurocognitive function evaluation in primary brain tumor patients on a prospective observational study utilizing a multi-dimensional app-based assessment tool. International Journal of Particle Therapy. 2024 Jun 1;12:100258 | 2024 |
| Madsen, J., Braghiroli, N. F., Yarlagadda, S., Rubens, M., & Kalman, N. S. Reflectance Confocal Microscopy Mapping of Non-melanoma Skin Cancers to Guide Definitive Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics, 118(5), e83-e84. | 2024 |
| Yarlagadda S, Kutuk T, Saxena A, Roy M, Tolakanahalli RP, Appel H, de Los Rios AL, Tom MC, Hall MD, Wieczorek DJ, Lee YC. Stereotactic Radiosurgery for Small Intact Brain Metastasis: A Comparative Evaluation of 3 Different Single Fraction Prescription Doses. International Journal of Radiation Oncology, Biology, Physics. 2023 Oct 1;117(2):e159-60. | 2023 |
| Kutuk T, Yarlagadda S, Tolakanahalli RP, Roy M, Saxena A, Hall MD, La Rosa A, Tom MC, Wieczorek DJ, Lee Y, Appel H. A Comparison of Local Failure and Necrosis Following Different Radiosurgery Strategies for Large Brain Metastases International Journal of Radiation Oncology, Biology, Physics. 2023 Oct 1;117(2):e121-2 | 2023 |
| Scott Roof, Glenn Hanna, James Jabalee, Eleni Rettig, Rocco Ferrandino, Sida Chen, Marshall R. Posner, Krzysztof J. Misiukiewicz, Eric M. Genden, Raymond L. Chai, John Sims, Elaine Thrash, Scott Stern, Noah S. Kalman, Sreenija Yarlagadda, Adam Raben, et al Utility of circulating tumor tissue modified viral (TTMV)-HPV DNA to resolve clinically indeterminate findings in patients following definitive treatment for HPV-driven oropharyngeal cancer. Clin Cancer Res 15 September 2023; 29 | 2023 |
| Yarlagadda S, Kutuk T, Saxena A, Roy M, Tolakanahalli R, Appel H, et al. Predicting Risk of Distant Brain Failure with Radiosurgery and Systemic Therapy in a Diverse NSCLC Brain Metastasis Population. J Thorac Oncol 2023;18:S303. | 2023 |
| Dutta D, Sreenija Y, Reddy S, Nair H, SK N, Sasidharan A, Kannan R, George S, EH A, Haridas NK, Jose W. Response and survival function correlation with CyberKnife in 209 HCC pt with portal vein thrombus. Radiotherapy and Oncology. 2023 May 1;182:S741-2. | 2023 |
| Sreenija Y, Nizar AA, Sasidharan A, Kalavagunta S, Dutta D. In-field axial cardiac contact distance-a measure of adequate breath-hold in breast cancer radiation Radiotherapy and Oncology. 2023 May 1;182:S1026-7. | 2023 |
| Gonzalez, L., Yarlagadda, S., Rubens, M., & Kalman, N. S. Hypofractionated Radiotherapy for Merkel Cell Carcinoma. International Journal of Radiation Oncology, Biology, Physics, 118(5), e84. | 2023 |
| Kalman, N. S., Yarlagadda, S., McAllister, N., Rzepczynski, A. E., & Kutuk, T. Tubarial Gland Sparing with Intensity-Modulated Radiation Therapy for Oropharyngeal Cancers: A Pilot Study of Dosimetric Feasibility. International Journal of Radiation Oncology, Biology, Physics, 118(5), e23-e24. | 2023 |
| Kamath R, K S, Gupte A, Sreenija Y, U PK, R A, et al Prospective evaluation of robotic radiosurgery in Indian patients with oligo-metastases Radiother Oncol. 2021 Aug 1;161:S1242–3 | 2021 |
| Dutta D, Reddy SK, Sreenija Y, Nair HM, Sasidharan A, Gupte A, et al Indian experience of 100 HCC patients with portal vein thrombosis treated with robotic radiosurgery Radiother Oncol. 2021 Aug 1;161:S1006 | 2021 |
| Sreenija Y, K S, Nair H, Sasidharan A, Pottayil SG, E H A, et al Prospective evaluation of Child Pugh score as a tool for assessment of acute toxicity in liver SBRT. Radiother Oncol. 2021 Aug 1;161:S1010 | 2021 |
Book Chapter | |
| Sreenija Yarlagadda MD, Noah S. Kalman MD, MBA Radiation therapy in head and neck cancer Head and Neck Cancer Rehabilitation | |
| Debnarayan Dutta, Sreenija Yarlagadda Radiation Induced Liver Toxicity Hepatotoxicity, Oct 2022 | |
Editorial | |
| Kalman NS, Yarlagadda S, In Regard to Youssef et al. International journal of radiation oncology, biology, physics, 2024 Dec 1;120(5):1458-1459 | 2024 |
Presentations
| Platform Presentations, Implementation of real-time tracking for early larynx cancer with MR-LINAC, 30th annual Kukuna O Ka La Radiation Oncology Conference, Hawaii, USA | 01/2026 |
| Platform Presentations, Deep Quantitative Assessment of Metabolic Mucosal Changes with Variable Relative Biological Effectiveness of Head and Neck Proton Therapy, American Society for Radiation Oncology (ASTRO) | 09/2025 |
| Poster Presentation, Timing and Predictors of Grade 3 Lymphopenia in Lung Cancer Patients Undergoing Proton Chemoradiotherapy, American Society for Radiation Oncology (ASTRO), San Francisco, USA | 09/2025 |
| Poster Presentation, Normal Tissue Complication Probability Model Predicting the Risk of Radiation Necrosis after Stereotactic Radiosurgery for Small Brain Metastases, American Society for Radiation Oncology (ASTRO), San Francisco, USA | 09/2025 |
| Poster Presentation, Taste Changes in Patients Receiving Head and Neck Radiation–Initial Analysis from a Prospective Study., American Society for Radiation Oncology (ASTRO), Washington DC, USA | 10/2024 |
| Poster Presentation, Development of a Machine Learning-Based Tool to Predict Local Failure after Stereotactic Radiosurgery for Small Brain Metastases, American Society for Radiation Oncology (ASTRO), Washington DC, USA | 09/2024 |
| Platform Presentations, Post-radiotherapy neurocognitive function evaluation in primary brain tumor patients on a prospective observational study utilizing a multi-dimensional app-based assessment tool, 62nd Annual Particle Therapy Co-operative Group (PTCOG) Conference, Singapore | 06/2024 |
| Platform Presentations, Connectome analysis & cognitive outcomes post Whole-brain RT: Prospective registry’s first analysis, European Society for Radiotherapy and Oncology (ESTRO), Glasgow, Scotland | 05/2024 |
| Platform Presentations, Machine Learning to predict time to local failure & radionecrosis post-brain metastasis radiosurgery., European Society for Therapeutic Radiology and Oncology (ESTRO) conference, Glasgow, Scotland | 05/2024 |
| Platform Presentations, Evaluating dose parameters for cognitive decline post-radiosurgery measured by App-based assessment, European Society for Radiotherapy and Oncology (ESTRO), Glasgow, Scotland | 05/2024 |
| Poster Presentation, Utilization of proton therapy for retroperitoneal sarcomas using prospective multi-institutional PCG registry, Particle Therapy Cooperative Group – North America (PTCOG-NA) 9th Annual Conference, Seattle, USA | 10/2023 |
| Poster Presentation, Stereotactic Radiosurgery for Small Intact Brain Metastasis: A Comparative Evaluation of 3 Different Single Fraction Prescription Doses, American Society for Radiation Oncology (ASTRO), San Diego, USA | 10/2023 |
| Poster Presentation, Dose-escalated Preoperative Proton Therapy For Retroperitoneal Sarcomas: Initial Outcomes of a New Treatment Paradigm., American College of Radiation Oncology, Orlando, USA | 03/2023 |
| Poster Presentation, Radical radiation therapy with Tomotherapy in Carcinoma oropharynx, larynx, hypopharynx: Indian experience, European Congress on Head and Neck Oncology (ECHNO)-Innovative Approaches in Head and Neck Oncology (ICHNO), Virtual | 03/2022 |
| Platform Presentations, Hepatocellular carcinoma patients with portal vein thrombosis treated with robotic radiosurgery: Interim results from a prospective study, 8th Annual Young Radiation Oncologist Conference (YROC), Coimbatore, India | 01/2021 |
Professional Membership and Service
| American Society for Radiation Oncology (ASTRO), Member | |
| National Hispanic Medical Association (NHMA), Member | |
| SIGMA XI- The Scientific Research Honors Society, Member | |
| Florida Society of Clinical Oncology (FLASCO), Member | |
| Association of Radiation Oncologists of India (AROI), Member | |
| European Society for Radiation Oncology (ESTRO), Member |